Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,291 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $518.77 | 11 | $0 (2024) |
| Novo Nordisk Inc | $503.74 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $407.13 | 5 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $338.83 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $228.86 | 7 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $217.99 | 2 | $0 (2023) |
| PFIZER INC. | $203.35 | 10 | $0 (2024) |
| Lilly USA, LLC | $187.71 | 5 | $0 (2024) |
| Amgen Inc. | $173.13 | 4 | $0 (2024) |
| Medtronic, Inc. | $170.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.93 | 9 | Lilly USA, LLC ($161.00) |
| 2023 | $650.45 | 14 | AbbVie Inc. ($136.03) |
| 2022 | $764.34 | 15 | Medtronic, Inc. ($170.64) |
| 2021 | $441.61 | 12 | Novo Nordisk Inc ($171.42) |
| 2020 | $63.01 | 4 | Astellas Pharma US Inc ($29.79) |
| 2019 | $320.97 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($114.22) |
| 2018 | $713.43 | 17 | AstraZeneca Pharmaceuticals LP ($157.57) |
| 2017 | $928.56 | 13 | AstraZeneca Pharmaceuticals LP ($249.56) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes Care | ||||||
| 10/10/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $140.15 | General |
| Category: LIVER DISEASE | ||||||
| 08/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.85 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Inflammation | ||||||
| 04/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $100.99 | General |
| Category: Cardio-renal | ||||||
| 09/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: VACCINES | ||||||
| 08/23/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $111.28 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/12/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Oncology | ||||||
| 05/20/2023 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: OSTEOPOROSIS | ||||||
| 04/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/03/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $120.85 | General |
| Category: INSOMNIA | ||||||
| 02/22/2023 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Neuroscience | ||||||
| 01/12/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,582 | 1,936 | $255,135 | $133,995 |
| 2022 | 16 | 1,712 | 2,011 | $231,800 | $137,238 |
| 2021 | 19 | 1,255 | 1,515 | $181,010 | $109,928 |
| 2020 | 16 | 969 | 1,262 | $154,835 | $79,582 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 613 | $110,490 | $57,511 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 232 | 232 | $41,830 | $31,378 | 75.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 67 | 67 | $26,800 | $9,609 | 35.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 250 | 250 | $12,500 | $4,770 | 38.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 235 | 235 | $11,750 | $4,484 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 64 | 66 | $4,290 | $4,204 | 98.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 27 | 28 | $9,520 | $4,129 | 43.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 18 | $6,210 | $3,986 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 84 | $10,080 | $3,165 | 31.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,250 | $2,269 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 68 | $2,380 | $2,233 | 93.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 24 | $2,400 | $1,955 | 81.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 57 | 62 | $3,720 | $1,465 | 39.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 45 | $3,375 | $1,194 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 91 | 100 | $4,500 | $1,018 | 22.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 11 | 11 | $1,540 | $436.26 | 28.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 20 | $500.00 | $190.40 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 273 | 539 | $97,255 | $50,310 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 241 | 241 | $43,380 | $33,209 | 76.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 243 | 243 | $24,300 | $18,819 | 77.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 123 | $14,760 | $9,204 | 62.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 257 | 257 | $12,850 | $5,022 | 39.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 236 | 236 | $11,800 | $4,530 | 38.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 55 | 56 | $3,640 | $3,578 | 98.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $4,485 | $3,061 | 68.3% |
About Dr. Jane Cohen, MD
Dr. Jane Cohen, MD is a Internal Medicine healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417953514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Cohen, MD has received a total of $4,291 in payments from pharmaceutical and medical device companies, with $408.93 received in 2024. These payments were reported across 98 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,291).
As a Medicare-enrolled provider, Cohen has provided services to 5,518 Medicare beneficiaries, totaling 6,724 services with total Medicare billing of $460,743. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location North Miami, FL
- Active Since 06/23/2005
- Last Updated 08/27/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417953514
Products in Payments
- OCALIVA (Drug) $263.26
- FARXIGA (Drug) $246.21
- Kerendia (Drug) $217.99
- Ozempic (Drug) $188.00
- ARCTIC FRONT ADVANCE (Device) $170.64
- VIBERZI (Drug) $164.80
- BYDUREON (Drug) $160.92
- NURTEC ODT (Drug) $158.41
- MOUNJARO (Drug) $154.56
- LINZESS (Drug) $141.69
- REZDIFFRA (Drug) $140.15
- TRELEGY ELLIPTA (Drug) $129.62
- RYBELSUS (Drug) $125.00
- CREON (Drug) $124.99
- Humira (Biological) $124.83
- Tresiba (Drug) $124.56
- Repatha (Biological) $124.54
- Arctic Front (Device) $121.35
- MYRBETRIQ (Drug) $120.97
- QUVIVIQ (Drug) $120.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Miami
Mr. Manuel Suarez Barcelo, Md, MD
Internal Medicine — Payments: $240,589
Sheren Leung, D.o, D.O
Internal Medicine — Payments: $12,126
Dr. Gilbert Leung, M.d, M.D
Internal Medicine — Payments: $8,321
Dr. Nasiruddin Nazarally, M.d, M.D
Internal Medicine — Payments: $6,825
Dr. Luis Perez, D.o, D.O
Internal Medicine — Payments: $5,990
Eliades Carmenate, M.d, M.D
Internal Medicine — Payments: $5,003